TABLE 3

Summary of treatment-emergent adverse events

TEAEaResults (no. [%] of patients) in:
Cohort I (n = 6)Cohort II (n = 6)Cohort III (n = 6)Total (n = 18)
At least 12 (33.3)2 (33.3)3 (50.0)7 (38.9)
Related to the study drug1 (16.7)1 (16.7)0 (0)2 (11.1)
  • a Treatment-emergent adverse events.